Zobrazeno 1 - 3
of 3
pro vyhledávání: '"O. N. Volovikova"'
Publikováno v:
Health and Ecology Issues. :30-34
The new immunosuppressive drug Leflunomide has been used in the treatment of rheumatoid arthritis recently. By its efficiency Leflunomide is not inferior to the long known basic drug - Methotrexate. In most cases, Leflunomide is well tolerated. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fd976b317fae5c34da5df87bf8fee0a
https://doi.org/10.51523/2708-6011.2014-11-4-5
https://doi.org/10.51523/2708-6011.2014-11-4-5
Publikováno v:
Health and Ecology Issues. :18-21
At present, Leflunomide is a good alternative to Methotrexate in the treatment for rheumatoid arthritis. It can inhibit two enzymes: dihydroorotate dehydrogenase and tyrosine kinase and lead to the development of antiproliferative, antiinflammatory,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a4c798a6ac99f51ff4296ab916565e7
https://doi.org/10.51523/2708-6011.2014-11-2-3
https://doi.org/10.51523/2708-6011.2014-11-2-3
Autor:
O. N. Volovikova, E. I. Mikhailova
Publikováno v:
Health and Ecology Issues. :13-18
Research objective: to study the role of metabolism fermental systems in biotransformation of various medicines, to define the value of pharmagenetics in the development of personalized medicine. Material of research: the publications containing info
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce4e5a588fbf18e73ce8b7b4ac6aecaa
https://doi.org/10.51523/2708-6011.2012-9-2-2
https://doi.org/10.51523/2708-6011.2012-9-2-2